{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:51:50Z","timestamp":1760147510937,"version":"build-2065373602"},"reference-count":75,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The likelihood of a diagnosis of dementia increases with a person\u2019s age, as is also the case for many cancers, including melanoma and multiple myeloma, where the median age of diagnosis is above 60 years. However, patients diagnosed with dementia are less likely to be offered invasive curative therapies for cancer. Together with analysis of diet and medication history, advanced imaging methods and genetic profiling can now indicate more about syndromes causing the neurological symptoms. Cachexia, malnutrition, dehydration, alcohol consumption, and even loneliness can all accentuate or cause the \u201c3Ds\u201d of dementia, delirium and depression. Many common drugs, especially in the context of polypharmacy, can cause cognitive difficulties resembling neurodegenerative disease. These syndromes may be reversed by diet, social and caregiver changes, and stopping potentially inappropriate medications (PIMs). More insidious are immune reactions to many different autoantigens, some of which are related to cancers and tumors. These can induce movement and cognitive difficulties that mimic Alzheimer\u2019s and Parkinson\u2019s diseases and other ataxias associated with aging. Paraneoplastic neurological syndromes may be reversed by directed immunotherapies if detected in their early stages but are best treated by removal of the causative tumor. A full genetic workup should be done for all individuals as soon as possible after diagnosis, to guide less invasive treatments suitable for frail individuals. While surgical interventions may be contraindicated, genetic profile guided immunotherapies, oral treatments, and radiation may be equally curative in a significant number of cancers.<\/jats:p>","DOI":"10.3390\/cancers15041055","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T01:32:05Z","timestamp":1675819925000},"page":"1055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Distinguishing Curable from Progressive Dementias for Defining Cancer Care Options"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-2109","authenticated-orcid":false,"given":"Catherine H.","family":"Schein","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Institute for Human Infections and Immunity, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"ref_1","unstructured":"(2023, February 03). National Cancer Institute Age and Cancer Risk, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/all.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ageing\/afaa210","article-title":"Understanding and identifying ways to improve hospital-based cancer care and treatment for people with dementia: An ethnographic study","volume":"50","author":"Ashley","year":"2021","journal-title":"Age Ageing"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11910-020-01074-y","article-title":"Psychosis in Alzheimer\u2019s Disease","volume":"20","author":"Ballard","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_4","first-page":"208","article-title":"Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy","volume":"25","author":"Jicha","year":"2019","journal-title":"Continuum"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12247","DOI":"10.1002\/trc2.12247","article-title":"The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L\/COMT- and rTg(P301L)4510 mouse models of Alzheimer\u2019s disease","volume":"8","author":"Jimenez","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref_6","first-page":"510","article-title":"Rapidly Progressive Dementia","volume":"22","author":"Geschwind","year":"2016","journal-title":"Continuum"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e13019","DOI":"10.1111\/eci.13019","article-title":"Cancer and dementia: Two sides of the same coin?","volume":"48","author":"Schagen","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e225155","DOI":"10.1001\/jamasurg.2022.5155","article-title":"Population-Based Estimates of 1-Year Mortality After Major Surgery among Community-Living Older US Adults","volume":"157","author":"Gill","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"pkab002","DOI":"10.1093\/jncics\/pkab002","article-title":"The Impact of Dementia on Cancer Treatment Decision-Making, Cancer Treatment, and Mortality: A Mixed Studies Review","volume":"5","author":"Caba","year":"2021","journal-title":"JNCI Cancer Spectr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11154-017-9420-5","article-title":"Clinical aspects of changes in water and sodium homeostasis in the elderly","volume":"18","author":"Koch","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_12","unstructured":"Preskin, S.M. (2022). A Molecule Away from Madness: Tales of the Hijacked Brain, W. W. Norton & Company."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5694\/mja2.51254","article-title":"New Australian guidelines for the treatment of alcohol problems: An overview of recommendations","volume":"215","author":"Haber","year":"2021","journal-title":"Med. J. Aust."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jamda.2021.12.021","article-title":"Reimagining Nutrition Care and Mealtimes in Long-Term Care","volume":"23","author":"Keller","year":"2022","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40266-020-00821-7","article-title":"Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-Based Care Team","volume":"38","author":"Levine","year":"2021","journal-title":"Drugs Aging"},{"key":"ref_16","first-page":"1402","article-title":"Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case-time-control design","volume":"30","author":"Chyou","year":"2021","journal-title":"Pharm. Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc., 67, 674\u2013694.","DOI":"10.1111\/jgs.15767"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1984.e9","DOI":"10.1016\/j.jamda.2022.08.015","article-title":"Point-of-Care Saliva Osmolarity Testing for the Screening of Hydration in Older Adults With Hypertension","volume":"23","author":"Atjo","year":"2022","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcpt.12632","article-title":"A Danish Survey of Antihistamine Use and Poisoning Patterns","volume":"120","author":"Jensen","year":"2017","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3233\/JAD-220294","article-title":"Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer\u2019s Disease Prior to Overt Global Amyloid Positivity","volume":"88","author":"Ali","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0037-1608808","article-title":"Neuroimaging in Dementia","volume":"37","author":"Staffaroni","year":"2017","journal-title":"Semin. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","article-title":"Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease","volume":"126","author":"Nelson","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2215-0366(20)30431-4","article-title":"Neuropsychiatric symptoms associated with cerebral small vessel disease: A systematic review and meta-analysis","volume":"8","author":"Clancy","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-021-24220-7","article-title":"Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer\u2019s disease","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Al-Janabi, O.M., Bauer, C.E., Goldstein, L.B., Murphy, R.R., Bahrani, A.A., Smith, C.D., Wilcock, D.M., Gold, B.T., and Jicha, G.A. (2019). White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable Groups. Brain Sci., 9.","DOI":"10.3390\/brainsci9070170"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1038\/s41598-022-14812-8","article-title":"Near-infrared light reduces glia activation and modulates neuroinflammation in the brains of diet-induced obese mice","volume":"12","author":"Saieva","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-2573-6_13","article-title":"Pharmacogenomics of Alzheimer\u2019s Disease: Novel Strategies for Drug Utilization and Development","volume":"2547","author":"Cacabelos","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_29","first-page":"101311","article-title":"Development of a novel pharmacophore model to screen specific inhibitors for the serine-threonine protein phosphatase calcineurin","volume":"31","author":"Mukherjee","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00018-022-04255-9","article-title":"Abeta\/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer\u2019s disease","volume":"79","author":"Marcatti","year":"2022","journal-title":"Cell Mol. Life. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials","volume":"79","author":"Ostrowitzki","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/psp4.12862","article-title":"Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer\u2019s disease","volume":"11","author":"Hayato","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/med.21627","article-title":"Repurposing approved drugs on the pathway to novel therapies","volume":"40","author":"Schein","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1523\/JNEUROSCI.0361-21.2021","article-title":"Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain","volume":"41","author":"Radhakrishnan","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.bmc.2009.05.047","article-title":"Computational selection of inhibitors of Abeta aggregation and neuronal toxicity","volume":"17","author":"Chen","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/ADR-190104","article-title":"Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer\u2019s Disease via Peroxisome Proliferator-Activated Receptor alpha","volume":"3","author":"Chandra","year":"2019","journal-title":"J. Alzheimers. Dis. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"eabg4747","DOI":"10.1126\/scisignal.abg4747","article-title":"Activation of PPARalpha enhances astroglial uptake and degradation of beta-amyloid","volume":"14","author":"Raha","year":"2021","journal-title":"Sci. Signal"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e12350","DOI":"10.1002\/trc2.12350","article-title":"The Alzheimer\u2019s Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer\u2019s disease","volume":"8","author":"Zhou","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-022-10133-y","article-title":"Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles","volume":"12","author":"Ibrahim","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41582-020-00433-0","article-title":"Implications of new genetic risk factors in prion disease","volume":"17","author":"Vallabh","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"d1918","DOI":"10.1136\/bmj.d1918","article-title":"Autoimmune encephalitis","volume":"342","author":"Irani","year":"2011","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/ebmental-2019-300110","article-title":"Autoimmune encephalitis in the elderly: Who to test and what to test for","volume":"22","author":"Behrman","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"ref_44","unstructured":"Zigmond, M.J., Wiley, C.A., and Chesselet, M.-F. (2023). Neurobiology of Brain Disorders, Academic Press. [2nd ed.]."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40673-021-00137-1","article-title":"Anti-Tr\/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years","volume":"8","author":"Christensen","year":"2021","journal-title":"Cerebellum Ataxias"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/PNXB5040","article-title":"Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT","volume":"26","author":"Jayne","year":"2022","journal-title":"Health Technol. Assess."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.omtm.2022.08.007","article-title":"GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy","volume":"27","author":"Chopra","year":"2022","journal-title":"Mol. Methods Clin. Dev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/bioinformatics\/btac335","article-title":"Examining clustered somatic mutations with SigProfilerClusters","volume":"38","author":"Bergstrom","year":"2022","journal-title":"Bioinformatics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","article-title":"Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA","volume":"602","author":"Bergstrom","year":"2022","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjc.6601676","article-title":"Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials","volume":"90","author":"Hoff","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jgo.2020.12.006","article-title":"Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study","volume":"12","author":"Martin","year":"2021","journal-title":"J. Geriatr. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"Chapman","year":"1999","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3747\/co.27.5135","article-title":"Use of immuno-oncology in melanoma","volume":"27","author":"Smylie","year":"2020","journal-title":"Curr. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2016.01.001","article-title":"The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer","volume":"130","author":"Ward","year":"2016","journal-title":"Adv. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1002\/onco.13601","article-title":"Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer","volume":"26","author":"Sena","year":"2021","journal-title":"Oncologist"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"(2022). Dostarlimab: An Answer for Rectal Cancer?. Cancer Discov., 12, 1828\u20131829.","DOI":"10.1158\/2159-8290.CD-NB2022-0047"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/j.annonc.2022.08.016","article-title":"LBA7\u2014Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study","volume":"33","author":"Chalabi","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.13424","article-title":"Immune checkpoint inhibitor diabetes mellitus: A novel form of autoimmune diabetes","volume":"200","author":"Quandt","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3201\/eid2807.220127","article-title":"Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan","volume":"28","author":"Sato","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","article-title":"Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer","volume":"24","author":"Zacharakis","year":"2018","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3389\/fneur.2020.00996","article-title":"Management of MS Patients Treated With Daclizumab\u2014A Case Series of 267 Patients","volume":"11","author":"Rommer","year":"2020","journal-title":"Front Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s11864-022-00991-z","article-title":"How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia","volume":"23","author":"Moore","year":"2022","journal-title":"Curr. Treat. Options. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.20.02341","article-title":"Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes","volume":"39","author":"Sallman","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1535-7163.MCT-21-0067","article-title":"SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status","volume":"20","author":"Fujihara","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101974","DOI":"10.1016\/j.ctrv.2020.101974","article-title":"KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?","volume":"84","author":"Nagasaka","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/1381612023393161","article-title":"The shape of the messenger: Using protein structure information to design novel cytokine-based therapeutics","volume":"8","author":"Schein","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"ref_70","unstructured":"Weissmann, C., Nagata, S., Boll, W., Fountoulakis, M., Fujisawa, A., Fujisawa, J.-I., Haynes, J., Henco, K., Mantei, N., and Ragg, H. (1982). Interferons, Elsevier."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40487-018-0058-6","article-title":"A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected","volume":"6","author":"Winer","year":"2018","journal-title":"Oncol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hon.2786","article-title":"A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5)\u2014AGMT_CML 1","volume":"38","author":"Heibl","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bmb\/ldaa045","article-title":"Repurposing approved drugs for cancer therapy","volume":"137","author":"Schein","year":"2021","journal-title":"Br. Med. Bull."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5414\/CN109342","article-title":"Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature","volume":"89","author":"Mima","year":"2018","journal-title":"Clin. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00277-021-04467-2","article-title":"Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML\/SAKK30\/10 Swiss trial cohort","volume":"100","author":"Brune","year":"2021","journal-title":"Ann. Hematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/4\/1055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:27:04Z","timestamp":1760120824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/4\/1055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15041055"],"URL":"https:\/\/doi.org\/10.3390\/cancers15041055","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}